BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9916703)

  • 1. Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus.
    Kretz-Rommel A; Rubin RL
    J Immunol; 1999 Jan; 162(2):813-20. PubMed ID: 9916703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.
    Kretz-Rommel A; Duncan SR; Rubin RL
    J Clin Invest; 1997 Apr; 99(8):1888-96. PubMed ID: 9109433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cellular events in systemic autoimmunity driven by chromatin-reactive T cells.
    Kretz-Rommel A; Rubin RL
    Cell Immunol; 2001 Mar; 208(2):125-36. PubMed ID: 11333145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nondeletional mechanism for central T-cell tolerance.
    Rubin RL; Kretz-Rommel A
    Crit Rev Immunol; 2001; 21(1-3):29-40. PubMed ID: 11642611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
    Sainis K; Datta SK
    J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrathymic injection of organ-specific autoantigens, parietal cells, at the neonatal stage on autoreactive effector and suppressor T cell precursors.
    Murakami K; Maruyama H; Nishio A; Kuribayashi K; Inaba M; Inaba K; Hosono M; Shinagawa K; Sakai M; Masuda T
    Eur J Immunol; 1993 Apr; 23(4):809-14. PubMed ID: 8458371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell autoimmunity in Ig transgenic mice.
    Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
    J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K; Hamano T; Kakishita E
    Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.
    Portanova JP; Claman HN; Kotzin BL
    J Immunol; 1985 Dec; 135(6):3850-6. PubMed ID: 3877758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
    Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
    Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA
    J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
    Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T
    J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
    Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
    J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin.
    Portanova JP; Arndt RE; Kotzin BL
    J Immunol; 1988 Feb; 140(3):755-60. PubMed ID: 3339241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
    Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.